Clinical Trials for GDC-0032

2 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCBRE1320
08/16/2013
A Phase Ib Open-Label, Dose-Escalation Study of the Safety and Pharmacology of GDC-0032 in Combination with Either Docetaxel or Paclitaxel in Patients with HER2-Negative Locally Recurrent or Metastatic Breast Cancer
TreatmentVICCPHI1248
10/12/2012
An Open-Label, Phase I, Dose-Escalation Study Evaluating the Safety and Tolerability of GDC0032 in Patients with Locally Advanced or Metastatic Solid Tumors and in Combination with Endocrine Therapy in Patients with Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.